The reversal of multidrug resistance: an update
- 1 January 2003
- journal article
- review article
- Published by Wiley in Journal of Experimental Therapeutics and Oncology
- Vol. 3 (1) , 5-13
- https://doi.org/10.1046/j.1359-4117.2003.01067.x
Abstract
No abstract availableThis publication has 75 references indexed in Scilit:
- From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significanceCellular and Molecular Life Sciences, 2001
- Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemiaBritish Journal of Haematology, 2001
- Multidrug resistance (MDR) in cancerEuropean Journal of Pharmaceutical Sciences, 2000
- Multidrug resistance in oncology: diagnostic and therapeutic approachesEuropean Journal of Clinical Investigation, 1999
- Anti-psychotic drugs reverse multidrug resistance of tumor cell lines and human AML cells ex-vivoCancer Letters, 1999
- Synthesis of c-ring aromatic taxoids and evaluation of their multi-drug resistance reversing activityBioorganic & Medicinal Chemistry Letters, 1998
- Reversal of P-glycoprotein-mediated multidrug resistance in vitro by AV200, a new ardeemin derivativeCancer Letters, 1998
- A Novel Areneisonitrile Tc Complex Inhibits the Transport Activity of MDR P-GlycoproteinNuclear Medicine and Biology, 1998
- Aureobasidins as New Inhibitors of P-Glycoprotein in Multidrug Resistant Tumor Cells.The Journal of Antibiotics, 1998
- Inhibition of P-Glycoprotein ATPase Activity by Beryllium FluorideBiochemistry, 1997